A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature

被引:10
作者
Ge, Yan [1 ]
Lin, Xingtao [1 ]
Zhang, Fen [1 ]
Xu, Fangping [1 ]
Luo, Luqiao [1 ]
Huang, Weiye [1 ]
Liu, Zhihua [1 ]
Liu, Yanhui [1 ]
Li, Zhi [1 ]
机构
[1] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Pathol, 106,Zhongshan Rd 2, Guangzhou 510000, Guangdong, Peoples R China
关键词
Breast; Pseudomyogenic hemangioendothelioma; Epithelioid sarcoma-like hemangioendothelioma; CD31; FIBROMA-LIKE VARIANT; EPITHELIOID SARCOMA; TUMOR; SKIN;
D O I
10.1186/s13000-019-0857-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
AimsPseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) is a rare vascular tumor of intermediate malignancy that commonly occurs in soft tissue of distal extremities of young adults. PHE typically has a multifocal presentation and can involve several tissue planes, including the dermis, subcutis, muscle and bone.Methods and resultsWe present here a unique case of PHE/ESH that arose in the breast as well as a review of the published literature. The initial biopsy was interpreted as a metaplastic carcinoma. However, complete resection largely revealed plump epithelioid cells, and a more spindled cell component was also noted. The cells displayed abundant eosinophilic cytoplasm and central vesicular nuclei arranged in loose fascicles, with a mild, mixed acute and chronic inflammatory infiltrate. Overall, linear membranous staining of CD31 and lack of CD34 expression were highly suggestive of PHE. At the same time, FOSB immunoreactivity was observed, which supported PHE/ESH instead of metaplastic carcinoma. The patient has not shown recurrence in the half year follow up after total mastectomy.ConclusionTo our knowledge, this is the first report of breast involvement in this neoplasm. Recognition of its histopathological features and immunohistochemical reactivity will prevent misdiagnosis of breast lesions.
引用
收藏
页数:7
相关论文
共 23 条
[1]   Pseudomyogenic Hemangioendothelioma [J].
Al-Qaderi, Ayah ;
Mansour, Ahmad T. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (06) :763-767
[2]   Cutaneous pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma FOSB immunohistochemistry demonstrating the SERPINE1-FOSB fusion gene [J].
Alegria-Landa, V. ;
Santonja, C. ;
Jo-Velasco, M. ;
Kutzner, H. ;
Requena, L. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (12) :E550-E552
[3]   Epithelioid sarcoma-like hemangioendothelioma [J].
Billings, SD ;
Folpe, AL ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (01) :48-57
[4]  
Carter MR, 2006, AM J SURG PATHOL, V30, P300
[5]  
Fletcher CDM, 2013, PATHOLOGY GENETICS T
[6]  
Hornick JL, 2008, MODERN PATHOL, V21, p13A
[7]   Pseudomyogenic Hemangioendothelioma: A Distinctive, Often Multicentric Tumor With Indolent Behavior [J].
Hornick, Jason L. ;
Fletcher, Christopher D. M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (02) :190-201
[8]   FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma [J].
Hung, Yin P. ;
Fletcher, Christopher D. M. ;
Hornick, Jason L. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (05) :596-606
[9]   Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma [J].
Joseph, Jason ;
Wang, Wei-lien ;
Patnana, Madhavi ;
Ramesh, Naveen ;
Benjamin, Robert ;
Patel, Shreyaskumar ;
Ravi, Vinod .
CLINICAL SARCOMA RESEARCH, 2015, 5
[10]  
MIRRA JM, 1992, CANCER-AM CANCER SOC, V69, P1382, DOI 10.1002/1097-0142(19920315)69:6<1382::AID-CNCR2820690614>3.0.CO